OR WAIT null SECS
Farogh Gibraiel is senior downstream process development specialistat Polpharma Biologics S.A., Warsaw, Poland.
The authors have reviewed applications of novel technologies in the major stages of biosimilars development: process development, pharmacology, toxicology, and clinical trials, with an emphasis on recent regulatory requirements.